SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk
SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an individual’s risk of elevated...
Search results for "United States"
Seers Surpasses 200 Adopting Hospitals for ‘thynC,’ Upgrading Operations for Rapid Scaling
Seers, a leading wearable artificial intelligence diagnostic monitoring company, is sharpening its commercial strategy by recruiting a veteran...
Doctors Don’t Cure Cancer Alone: "Our Bodies Overcome It on Their Own"
Kim Eui-shin, a world-renowned cancer expert and lifetime professor at the MD Anderson Cancer Center, delivered a...
The Scalpel and the Flashlight: How a Post-War Korean Miracle Revolutionized Plastic Surgery
This week, I want to share a story that strikes a deeply moving narrative chord. Next week marks the 15th anniversary...
Measles, Not Ebola, Poses the Real Infectious Disease Risk for 2026 World Cup Fans
Ebola virus disease will not derail a soccer dream 52 years in the making. The Democratic Republic of the Congo men’s...
The Hidden Danger of Over-Brushing: How Diligent Oral Hygiene Can Silently Wear Down Your Smile
Taking a big bite of an apple becomes painful. Slurping cold noodles causes an involuntary wince the instant the icy...
Redefining K-Medicine: How Daegu’s W Hospital Became a National Hub for Hand Surgery
At the entrance of the pediatric orthopedic surgery department on the sixth floor of Daegu W Hospital, a large, vibrant...
Sweet Fruit, Bitter Risks: Why Experts Warn Against Pairing Grapefruit with Common Medications
Grapefruit is a subtropical fruit highly prized for its unique sweet-tart flavor, balancing a gentle sweetness with a...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...